NOTE: This article has been corrected to note CannTrust has not lost its NYSE listing over its low share price, but has been given six months to bring the price into compliance and meet the NYSE's minimum requirements for listing.

XX

Staff at CannTrust's Pelham facility has been cut by more than half since the Vaughan-based company's licences to grow and sell cannabis were suspended by Health Canada in September.

In July, Health Canada inspectors found cannabis being grown in unlicensed rooms there. They seized more than 4,000 kilograms of "implicated product" and took samples for more testing.

More than 350 staff worked at the Pelham operation on Balfour Road then.

At the same time, CannTrust put a voluntary hold on more of its product at its Vaughan processing plant.

Since September, CannTrust's licences to sell to grow cannabis and to sell to provincially authorized distributors or dealers, and to registered patients, have been suspended.

Most of the 149 workers who remain employed at the Pelham plant are production workers.

They are focused on remediation-related work the company expects will lead to reinstatement of its licences, said spokeswoman Jane Shapiro.

She declined to be interviewed, but in emails said remediation work includes an expanded internal training program, "strengthened governance and operations framework," and infrastructure improvements.

"The company anticipates completing all of the activities described within its remediation plan by the end of the first quarter of 2020," she wrote, "although completion will be subject to Health Canada's input and approval.

"To that end, the company and Health Canada are engaged on various aspects of the remediation plan."

Shapiro said: "… the company looks forward to rehiring members of its workforce, resuming production and once again delivering high-quality products to customers and patients."

As well as working from five unlicensed rooms, Health Canada also found CannTrust staff "provided false and misleading information" to inspectors and record keeping was "inadequate."

Chief executive officer Peter Aceto — he has since been replaced — admitted "errors in judgment."

Since then, the company has been working to bring itself into compliance. Health Canada's approval would be needed before CannTrust's licences are restored.

In October, CannTrust announced it would destroy $77 million worth of pot plants and inventory as part of its compliance plan.

CannTrust stock value has also been hit hard by the licence suspensions.

Loading... Loading... Loading... Loading... Loading... Loading...

On the New York Stock Exchange, its common shares' value dropped below the NYSE's minimum requirement of US$1 over a 30-day period. CannTrust now has six months to bring its share price into compliance.

Meanwhile, its eligibility to be listed on the Toronto Stock Exchange is under review over a failure to file some financial documents, the Canadian Press reported.

CannTrust is working to correct that with an independent auditor.